Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Kenneth Bernstein, M.D., receives Distinguished Scientist designation from American Heart Association

Kenneth Bernstein, MD, a Cedars-Sinai pathologist and scientific researcher known for expanding the understanding of a collection of proteins important in controlling blood pressure as well as heart and renal diseases, has been named a 2013 Distinguished Scientist by the American Heart Association.

Albumin marker flags incident CHD risk in blacks

Blacks with albuminuria appear to be at higher risk of incident coronary heart disease (CHD) than whites, according to a study published Aug. 21 in JAMA. But risk was similar for both races for recurrent CHD.

Heart risks prompt recall of herbal supplement

The manufacturer of an herbal supplement that is marketed for weight loss and other purposes is voluntarily recalling capsules that contain ingredients that may increase the risk of heart problems.

TRILOGY’s subplot: Fewer adverse events with angiography + prasugrel

In a subanalysis of TRILOGY ACS patients who had angiography, the prasugrel group had fewer adverse events than the clopidogrel group. Overall, patients who had angiography fared better than those who did not, a finding that editorial writers attributed to patient selection.

Thumbnail

MRI shows increase in aortic regurgitation after TAVI

Using cardiac MRI, researchers found that aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) did not decrease over time. Instead, the incidence and severity of paravalvular AR increased slightly at six-month follow-up.

Bioheart, Inc.'s President / CEO Mike Tomas appointed to workforce Florida board of directors by Governor Rick Scott

Bioheart, Inc. (OTCQB: BHRT) announced today that Mike Tomas, the company's President/CEO, has been appointed to serve on Workforce Florida's Board of Directors for a four year term by Florida Governor Rick Scott. Tomas is one of 15 Floridians appointed to the Board of Directors. Workforce Florida is charged with overseeing the state's workforce system and developing strategies that will improve the state's business environment while supporting its economy (www.EmployFlorida.com).

Mmm mmm, not so good for AHA

Californian Kerry O’Shea has filed a lawsuit against the American Heart Association (AHA) and Campbell Soup in a federal court in New Jersey under the New Jersey Consumer Fraud Act, taking aim at sodium levels in the Healthy Request brand, according to Bloomberg. The soup labels boast AHA’s “Heart-Check Mark” logo.

New cardiovascular intensive care unit offers specialized heart care for kids

Rady Children’s Hospital-San Diego today celebrated the grand opening of its new state-of-the-art Cardiovascular Intensive Care Unit (CVICU).

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.